Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

From Peyton Rous to the HPV Vaccine: A Journey of Discovery and Progress.

Meissner HC.

Pediatrics. 2019 Dec;144(6). pii: e20192345. doi: 10.1542/peds.2019-2345. Epub 2019 Nov 18. No abstract available.

PMID:
31740499
2.

Usability of encounter data for Medicaid comprehensive managed care vs traditional Medicaid fee-for-service claims among pregnant women.

Choi Y, Park H, Hampp C, Brumback B, Meissner HC, Li Y, Roussos-Ross D, Zhu Y, Henriksen C, Winterstein AG.

Pharmacoepidemiol Drug Saf. 2019 Nov 18. doi: 10.1002/pds.4923. [Epub ahead of print]

PMID:
31737976
3.

Complexity in Assessing the Benefit vs Risk of Vaccines: Experience With Rotavirus and Dengue Virus Vaccines.

Meissner HC.

JAMA. 2019 Oct 17. doi: 10.1001/jama.2019.16206. [Epub ahead of print] No abstract available.

PMID:
31621790
4.

The National Vaccine Injury Compensation Program: Striking a Balance Between Individual Rights and Community Benefit.

Meissner HC, Nair N, Plotkin SA.

JAMA. 2019 Jan 29;321(4):343-344. doi: 10.1001/jama.2018.20421. No abstract available.

PMID:
30608524
5.

Understanding FDA-Approved Labeling and CDC Recommendations for Use of Vaccines.

Meissner HC, Farizo K, Pratt D, Pickering LK, Cohn AC.

Pediatrics. 2018 Sep;142(3). pii: e20180780. doi: 10.1542/peds.2018-0780.

6.

Association of Age With Risk of Hospitalization for Respiratory Syncytial Virus in Preterm Infants With Chronic Lung Disease.

Winterstein AG, Choi Y, Meissner HC.

JAMA Pediatr. 2018 Feb 1;172(2):154-160. doi: 10.1001/jamapediatrics.2017.3792.

7.

Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines.

Kim L, Rha B, Abramson JS, Anderson LJ, Byington CL, Chen GL, DeVincenzo J, Edwards KM, Englund JA, Falsey AR, Griffin MR, Karron RA, Martin KG, Meissner HC, Munoz FM, Pavia AT, Piedra PA, Schaffner W, Simões EAF, Singleton R, Talbot HK, Walsh EE, Zucker JR, Gerber SI.

Clin Infect Dis. 2017 Sep 15;65(6):1020-1025. doi: 10.1093/cid/cix432.

8.

More on Viral Bronchiolitis in Children.

Meissner HC.

N Engl J Med. 2016 Sep 22;375(12):1200. doi: 10.1056/NEJMc1607283. No abstract available.

PMID:
27653586
9.

Vaccine Pricing and US Immunization Policies--Reply.

Meissner HC.

JAMA. 2016 Jul 12;316(2):226-7. doi: 10.1001/jama.2016.6322. No abstract available.

PMID:
27404202
10.

Viral Bronchiolitis in Children.

Meissner HC.

N Engl J Med. 2016 May 5;374(18):1793-4. doi: 10.1056/NEJMc1601509. No abstract available.

PMID:
27144864
11.

Immunization Policy and the Importance of Sustainable Vaccine Pricing.

Meissner HC.

JAMA. 2016 Mar 8;315(10):981-2. doi: 10.1001/jama.2016.0469. No abstract available.

PMID:
26857277
12.

Respiratory Syncytial Virus: A Byzantine Pathogen.

Meissner HC, Brady MT.

J Pediatr. 2016 Apr;171:6-8. doi: 10.1016/j.jpeds.2015.12.073. Epub 2016 Jan 19. No abstract available.

PMID:
26795683
13.

Viral Bronchiolitis in Children.

Meissner HC.

N Engl J Med. 2016 Jan 7;374(1):62-72. doi: 10.1056/NEJMra1413456. Review. No abstract available.

PMID:
26735994
14.

Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis. Pediatrics. 2014;134(5):e1474-e1502.

Ralston SL, Lieberthal AS, Meissner HC.

Pediatrics. 2015 Oct;136(4):782. doi: 10.1542/peds.2015-2862. No abstract available.

15.

In response to the letter from Braden.

Meissner HC, Hennessy S, Rowe E, Brady MT.

Pediatrics. 2014 Dec;134(6):e1783-4. doi: 10.1542/peds.2014-2901D. No abstract available.

PMID:
25452651
16.

Authors' responses in response to the letter from Ambrose.

Meissner HC, Brady MT, Byington CL, Kimberlin DW, Lieberthal AS, Maldonado YA, Ralston SL, Winterstein A.

Pediatrics. 2014 Dec;134(6):e1782-3. doi: 10.1542/peds.2014-2901C. No abstract available.

PMID:
25452650
17.

Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis.

Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, Johnson DW, Light MJ, Maraqa NF, Mendonca EA, Phelan KJ, Zorc JJ, Stanko-Lopp D, Brown MA, Nathanson I, Rosenblum E, Sayles S 3rd, Hernandez-Cancio S; American Academy of Pediatrics.

Pediatrics. 2014 Nov;134(5):e1474-502. doi: 10.1542/peds.2014-2742. Erratum in: Pediatrics. 2015 Oct;136(4):782.

PMID:
25349312
18.

Authors' response re: Clarifying costs and benefits of respiratory syncytial virus immunoprophylaxis.

Meissner HC, Kimberlin DW.

Pediatrics. 2014 Apr;133(4):e1101-3. doi: 10.1542/peds.2014-0077B. No abstract available.

PMID:
24692038
19.

RSV immunoprophylaxis: does the benefit justify the cost?

Meissner HC, Kimberlin DW.

Pediatrics. 2013 Nov;132(5):915-8. doi: 10.1542/peds.2013-2449. Epub 2013 Oct 14. No abstract available.

PMID:
24127478
20.

Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, Baker CJ, Messonnier NE; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2013 Mar 22;62(RR-2):1-28.

21.

Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for persons aged 0 through 18 years--United States, 2013.

ACIP Childhood/Adolescent Immunization Work Group, Akinsanya-Beysolow I, Jenkins R, Meissner HC; Centers for Disease Control and Prevention (CDC).

MMWR Suppl. 2013 Feb 1;62(1):2-8. No abstract available.

PMID:
23364302
22.

A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis.

Weisman LE, Thackray HM, Steinhorn RH, Walsh WF, Lassiter HA, Dhanireddy R, Brozanski BS, Palmer KG, Trautman MS, Escobedo M, Meissner HC, Sasidharan P, Fretz J, Kokai-Kun JF, Kramer WG, Fischer GW, Mond JJ.

Pediatrics. 2011 Aug;128(2):271-9. doi: 10.1542/peds.2010-3081. Epub 2011 Jul 25.

PMID:
21788224
23.

Guidelines for implementation of population-based newborn screening for severe combined immunodeficiency.

Comeau AM, Hale JE, Pai SY, Bonilla FA, Notarangelo LD, Pasternack MS, Meissner HC, Cooper ER, DeMaria A, Sahai I, Eaton RB.

J Inherit Metab Dis. 2010 Oct;33(Suppl 2):S273-81. doi: 10.1007/s10545-010-9103-9. Epub 2010 May 20.

PMID:
20490925
24.

The role of immunoprophylaxis in the reduction of disease attributable to respiratory syncytial virus.

Meissner HC, Bocchini JA Jr, Brady MT, Hall CB, Kimberlin DW, Pickering LK.

Pediatrics. 2009 Dec;124(6):1676-9. doi: 10.1542/peds.2009-2346. No abstract available.

PMID:
19948632
25.

Varicella prevention in the United States: a review of successes and challenges.

Marin M, Meissner HC, Seward JF.

Pediatrics. 2008 Sep;122(3):e744-51. doi: 10.1542/peds.2008-0567. Review.

PMID:
18762511
26.

Respiratory syncytial virus infection and recurrent wheezing: a complex relationship.

Meissner HC, Long SS.

J Pediatr. 2007 Jul;151(1):6-7. No abstract available.

PMID:
17586181
27.

Influenza vaccines: a pediatric perspective.

Meissner HC.

Curr Opin Pediatr. 2007 Feb;19(1):58-63. Review.

PMID:
17224663
28.

Elimination of rubella from the United States: a milestone on the road to global elimination.

Meissner HC, Reef SE, Cochi S.

Pediatrics. 2006 Mar;117(3):933-5. No abstract available.

PMID:
16510677
29.

Dose-response study of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children.

Shinefield H, Black S, Williams WR, Marchant C, Reisinger K, Stewart T, Meissner HC, Guerrero J, Klopfer SO, Xu J, Schödel F, Kuter BJ; Dose Selection Study Group for Proquad.

Pediatr Infect Dis J. 2005 Aug;24(8):670-5. Erratum in: Pediatr Infect Dis J. 2005 Nov;24(11):983.

PMID:
16094218
30.

Reducing the impact of viral respiratory infections in children.

Meissner HC.

Pediatr Clin North Am. 2005 Jun;52(3):695-710, v. Review.

PMID:
15925658
31.

Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children.

Belshe RB, Newman FK, Anderson EL, Wright PF, Karron RA, Tollefson S, Henderson FW, Meissner HC, Madhi S, Roberton D, Marshall H, Loh R, Sly P, Murphy B, Tatem JM, Randolph V, Hackell J, Gruber W, Tsai TF.

J Infect Dis. 2004 Dec 15;190(12):2096-103. Epub 2004 Nov 8.

PMID:
15551207
32.

Annual variation in respiratory syncytial virus season and decisions regarding immunoprophylaxis with palivizumab.

Meissner HC, Anderson LJ, Pickering LK.

Pediatrics. 2004 Oct;114(4):1082-4. No abstract available.

PMID:
15466107
33.

Measles vaccines and the potential for worldwide eradication of measles.

Meissner HC, Strebel PM, Orenstein WA.

Pediatrics. 2004 Oct;114(4):1065-9.

PMID:
15466106
34.

Unpredictable patterns of viral respiratory disease in children.

Meissner HC, Rennels MB.

Pediatrics. 2004 Jun;113(6):1814-6. No abstract available.

PMID:
15173514
35.

Risk of severe respiratory syncytial virus disease, identification of high risk infants and recommendations for prophylaxis with palivizumab.

Meissner HC, Rennels MB, Pickering LK, Hall CB.

Pediatr Infect Dis J. 2004 Mar;23(3):284-5. No abstract available.

PMID:
15014320
36.

Immunoprophylaxis with RespiGam.

Meissner HC, Rennels MB, Long SS, Pickering LK.

Pediatrics. 2004 Mar;113(3 Pt 1):629. No abstract available.

PMID:
14993568
37.

Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.

Meissner HC, Long SS; American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn.

Pediatrics. 2003 Dec;112(6 Pt 1):1447-52.

PMID:
14654628
38.

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease.

Feltes TF, Cabalka AK, Meissner HC, Piazza FM, Carlin DA, Top FH Jr, Connor EM, Sondheimer HM; Cardiac Synagis Study Group.

J Pediatr. 2003 Oct;143(4):532-40.

PMID:
14571236
39.

Hematologic effects of linezolid in young children.

Meissner HC, Townsend T, Wenman W, Kaplan SL, Morfin MR, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB.

Pediatr Infect Dis J. 2003 Sep;22(9 Suppl):S186-92.

PMID:
14520145
40.

Kawasaki syndrome: where are the answers?

Meissner HC, Leung DY.

Pediatrics. 2003 Sep;112(3 Pt 1):672-6. Review. No abstract available.

PMID:
12949301
41.

Selected populations at increased risk from respiratory syncytial virus infection.

Meissner HC.

Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S40-4; discussion S44-5. Review.

PMID:
12671451
42.

Technical report: Reduction of the influenza burden in children.

Rennels MB, Meissner HC; Committee on Infectious Diseases.

Pediatrics. 2002 Dec;110(6):e80. Review.

PMID:
12456947
43.

Control of disease attributable to Haemophilus influenzae type b and the national immunization program.

Meissner HC, Pickering LK.

Pediatrics. 2002 Oct;110(4):820-3. No abstract available.

PMID:
12359800
44.

Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease.

Leung DY, Meissner HC, Shulman ST, Mason WH, Gerber MA, Glode MP, Myones BL, Wheeler JG, Ruthazer R, Schlievert PM.

J Pediatr. 2002 Jun;140(6):742-6.

PMID:
12072880
45.

Influenza: emerging control of an old disease.

Meissner HC.

Pediatr Emerg Care. 2001 Dec;17(6):465-70. Review. No abstract available.

PMID:
11753198
46.

Antiviral drugs for prophylaxis and treatment of influenza.

Meissner HC.

Pediatr Infect Dis J. 2001 Dec;20(12):1165-7. Review. No abstract available.

PMID:
11740325
47.

Prevention of hepatitis B in adolescents.

Abramson JS, Baker CJ, Fisher MC, Gerber MA, Meissner HC, Murray DL, Overturf GD, Prober CG, Rennels MB, Saari TN, Weiner LB, Whitley RJ, Pickering LK; AAP Committee on Infectious Diseases, 2000-2001.

Pediatrics. 2001 Dec;108(6):1392. No abstract available.

PMID:
11731676
48.

Uncertainty in the management of viral lower respiratory tract disease.

Meissner HC.

Pediatrics. 2001 Oct;108(4):1000-3. Review. No abstract available.

PMID:
11581456
49.

Meningococcal disease among children who live in a large metropolitan area, 1981-1996.

Wang VJ, Kuppermann N, Malley R, Barnett ED, Meissner HC, Schmidt EV, Fleisher GR.

Clin Infect Dis. 2001 Apr 1;32(7):1004-9. Epub 2001 Mar 15.

PMID:
11264027
50.

Respiratory syncytial virus immunoprophylaxis: impact on epidemiology.

Dougherty NN, Meissner HC.

Paediatr Drugs. 2000 Mar-Apr;2(2):127-32.

PMID:
10937464

Supplemental Content

Loading ...
Support Center